In mammals, successful pregnancy is dependent in part on the adaptation or regulation of the maternal immune system to prevent the rejection of the embryonic semiallograft. A modification in Th cell function and secretion is a requirement for the establishment and maintenance of pregnancy. Although there is strong evidence from studies in humans and mice linking successful pregnancy with the predominance of Th2-type immunity, the situation in cattle remains unclear. This study describes the characterization of the immune response of the bovine maternal endometrium to the presence of a developing embryo, with specific emphasis on the macrophage and dendritic cell populations and associated factors, using quantitative real-time PCR, in situ hybridization, and immunohistochemistry. Furthermore, in vivo and in vitro models were developed to investigate the potential role of progesterone and interferon-tau (IFNT) in the regulation of these immune factors. There was a marked increase in the population of CD14 + cells and CD172a-CD11c + cells in the endometrium in response to pregnancy, which was paralleled by increased mRNA expression of a number of non-Th-associated factors, including IL12B and IL15, and downregulation of IL18. In addition, we identified several novel IFNT-and progesterone-regulated factors, including IL12B, MCP1, MCP2, PTX3, RSAD2, and TNFA, whose regulation may be critical to pregnancy outcome. Our findings give center stage to non-Th cells, such as monocytes/macrophages and dendritic cells, in the bovine immune response to the semiallogenic embryo. In conclusion, we propose that in cattle, successful pregnancy establishment is associated with a dramatic regulation of the cytokine network, primarily by endometrial monocytes/macrophages and dendritic cells.
INTRODUCTION
The initiation of pregnancy is marked by a number of immune modifications that occur in both the endometrium and the embryo and that require a coordinated crosstalk between these two partners [1] . Embryo implantation is one of the main steps of pregnancy involving endocrine and paracrine signals, such as steroid hormones and conceptus-derived interferon-tau (IFNT) in ruminants [2] , to support fetoplacental development. It also requires the mediation of a network of cytokines [3] , some under steroid control [4] , which can affect embryo viability and therefore the maintenance of pregnancy. Cytokines are pleiotropic glycoproteins with a well-documented role in reproductive physiology [5] . Lymphocyte cytokine production is classified into two categories: a cell-mediated immune response (Th1), where proinflammatory molecules are secreted, and a humoral response (Th2), which is characterized by the release of anti-inflammatory factors [6] .
In humans, pregnancy has been described as a Th1/Th2 dichotomy with an imbalance toward a Th2 immune response type [7, 8] . The Th1/Th2 paradigm is considered a simplistic explanation of the molecular events occurring during pregnancy [9] , which is inadequate to account for high expression of Th1-type cytokines as reported in the murine uterus at the implantation stage [10] . In ruminants, studies investigating maternal immunomodulation by pregnancy have focused on the actions of IFNT, the main maternal recognition factor of pregnancy [11] , which appears to be the key regulator of the maternal immune response in ruminants [12] . In recent years, macrophages (MUs) and dendritic cells (DCs) have been shown to infiltrate the human decidua during the first trimester [13, 14] , and their depletion has deleterious effects on the processes of implantation and placental development [15, 16] , suggesting their importance in immunoregulation and embryo tolerance. Unlike DCs, for which no study has been done in the context of pregnancy in ruminants, both peripheral and endometrial MU populations have been described after placentation in cattle [17] [18] [19] . To date, information is limited regarding the regulation of the key immune cells and immune factors during the preimplantation and peri-implantation periods in cattle.
The current study implicates for the first time MUs and DCs and their associated factors in the endometrial immune response to early pregnancy in cattle and provides clear evidence that progesterone (P4) and IFNT are key regulators of this response.
Immunohistochemical analysis of endometrial monocytes (MOs)/MUs and DCs was performed to determine 1) the temporal regulation of immune cells during the estrous cycle and pregnancy and 2) the impact of pregnancy on the immune cell profile.
Experiment 2: Expression of Immune-Related Factors During the Estrous Cycle and Early Pregnancy
The mRNA expression profile of a panel of candidate immune factors (n ¼ 11) was characterized as described in experiment 1.
Experiment 3: P4 Regulation of Bovine Endometrial Immune Factor Expression
A portion of the above treated heifers (n ¼ 70) received a P4-releasing intravaginal device containing 1.55 g of progesterone (CEVA Animal Health Ltd., Chesham, U.K.) on Day 3 of the estrous cycle or pregnancy, which significantly elevated progesterone concentrations from Days 3.5 to 8. This resulted in four treatment groups-1) cyclic, normal P4: CN; 2) cyclic, high P4: CH; 3) pregnant, normal P4: PN; and 4) pregnant, high P4: PH-on Days 5, 7, 13, and 16 of the estrous cycle or pregnancy, as previously described [20, 21] .
Experiment 4: IFNT Regulation of Bovine Endometrial Immune Factor Expression
Briefly, beef cows (Charolais) were synchronized as described above. On Day 14 after estrous, a single intrauterine infusion (25 ml per horn) of 0.9% (wt/vol) NaCl solution containing recombinant ovine IFNT (200 lg/ml) or vehicle was administered as previously published [22, 23] . Five animals from each group were slaughtered 2 h after infusion. Endometrial samples were collected as described above.
Primary endometrial cell culture (fibroblasts and glandular epithelial cells) was performed, and cell cultures were treated for 30 min, 2 h, or 24 h with 100 ng/ml ovine recombinant IFNT as previously described [24] . Control cells were left untreated.
Experiment 5: Expression and Localization of Candidate Immune Factors During Implantation and Placentation
Charolais beef heifers were estrous synchronized by the Crestar method, and half of them were artificially inseminated as previously described [25] . Animals were slaughtered on Day 20 of the estrous cycle and on Days 20, 25, and 60 of pregnancy (n ¼ 5 per time point). Endometrial samples were collected as described above for each time point and processed for either RNA or in situ hybridization.
Tissue Processing for RNA Extraction, Immunohistochemistry, and In Situ Hybridization
After collection, endometrial samples were immersed in 1:5 (wt/vol) RNAlater before being transferred to RNase/DNase-free tubes and stored at À808C for RNA extraction. Cross sections of endometrium were fixed in 4% (wt/vol) paraformaldehyde for immunohistochemistry (n ¼ 5 per stage and condition) and in situ hybridization (n ¼ 3 per stage and condition), then washed in PBS 13 followed by 15% and 18% (wt/vol) sucrose solution. Sections were then embedded in Tissue Tek (Sakura Finetek, Dublin, Ireland) and frozen by liquid nitrogen vapors.
Immunohistochemistry
Single-color immunofluorescence for MO/MU was performed by incubation at 48C overnight with primary antibodies (VMRD Inc., Pullman, WA), mouse anti-bovine CD14 immunoglobulin G1 (IgG1; clone MM61A; ascites, 10 mg/ml; 1:500), or mouse anti-bovine CD11b IgG1 (clone MM12a; ascites, 1 mg/ml; 1:500). The sections were then washed in Tris-buffered saline (3 3 5 min) and incubated with a secondary antibody (Alexa Fluor 594 goat antimouse IgG [catalogue no. A-11032; Invitrogen, Eugene, OR]) for 30 min at room temperature. Two-color immunofluorescence labeling was carried out for granulocytes/DCs by concomitant incubation of sections with primary antibodies mouse anti-bovine CD11c IgM (clone BAQ153A; ascites, 10 mg/ ml; 1:200; VMRD) and anti-human CD172a IgG1 (clone DH59B; ascites, 1 mg/ml; 1:500; VMRD), followed by incubation with secondary antibodies Alexa Fluor 488 goat anti-mouse IgG (H&L; catalogue no. A-1109) and Alexa Fluor 594 goat anti-mouse IgM (catalogue no. A-21042), also concomitantly. Negative controls were simultaneously performed by incubation with a matched isotype control (10 mg/ml; 1:500), followed by incubation with an appropriate secondary antibody. Following repeated washing in Tris-buffered saline, the sections were incubated with Hoechst 33342 reagent (2.3 mg/ml for 15 min) for DNA labeling and washed again, and coverslips were mounted using Prolong Antifade mounting medium (Invitrogen). The slides were examined using a Zeiss Axioplan 2 epifluorescence microscope (Zeiss, Gottingen, Germany) with Zeiss filters 02 (4 0 ,6-diamidino-2-phenylindole filter), 03 (fluorescein isothiocyanate filter), and 15 (rhodamine filter) at 403 magnification. Digital images were acquired using AxioVision software (Zeiss) and a high-resolution black-and-white Zeiss AxioCam MRm digital camera. Five random fields within each endometrial region were captured for morphometric analysis: luminal epithelium (LE), shallow stroma (SS), deep stroma (DS), and myometrium, and the number of positive cells was counted in each region, within a 2.25 mm 2 field of view (FOV). For the epithelium, squares were chosen for counting so as to ensure that the entire area of the square was within the epithelium. Data were analyzed by least square analysis of variance using the General Linear Models procedure of SAS (SAS Institute Inc., Cary, NC). Data were analyzed separately for each of the four regions. The mathematical model included effects of treatment (pregnant vs. nonpregnant and day after artificial insemination) and standard error.
Quantitative Real-Time PCR Total RNA was extracted from predominantly intercaruncular endometrium using Trizol reagent (Invitrogen, Carlsbad, CA), followed by on-column DNase digestion and RNA cleanup using the Qiagen mini kit (Qiagen, Crawley, U.K.) as per the manufacturer's instructions. Complementary DNA was synthesized from 1 lg of purified total RNA. The mRNA expression profiles of selected candidate genes were analyzed by quantitative real-time PCR (qPCR) using the ABI Prism 7500 FAST sequence detection system and Fast SYBR Green Master Mix (Applied Biosystems, Warrington, U.K.). Primers were designed for each gene of interest (Primer Express Software v2.0; Applied Biosystems; Supplemental Table S1 ; all Supplemental Data are available online at www. biolreprod.org), the specificity of all primers was confirmed both by melt-curve analysis and by sequencing of the amplified PCR fragments, and primer efficiency was determined using a serial dilution of Bos taurus-derived cDNA (1:4 dilution series over seven points). A normalization factor was calculated as the geometric mean of reference targets ACTB, RPL19, and PPIA (geNorm V , 0.45, using the geNorm application within the qbase PLUS software package [26] (Biogazelle, Zwijnaarde, Belgium). Calibrated normalized relative quantities (CNRQs) of gene expression for each analyzed sample were generated by the qbase PLUS package. All statistical analyses were carried out using the SAS v9.1.3 software package (SAS Institute). The data were log transformed in the TRANSREG procedure of SAS [27, 28] . The CNRQ measurements were analyzed using a linear mixed model (PROC MIXED). The statistical model included the effects of status (pregnant or cyclic), level (high or normal progesterone), and time (day of pregnancy or day of estrous cycle), and all possible interactions. These effects and their interactions were kept in MANSOURI-ATTIA ET AL.
the model if their P value was less than 0.25. All candidate gene CNRQs were included in the initial model as covariates. Acceptable significant levels were declared P , 0.05. A Bonferroni adjustment was used to account for multiple comparisons and results are reported as least square means 6 SEM unless otherwise stated.
Nonradioactive In Situ Hybridization
Using PCR-amplified cDNA templates generated with gene-specific primers, digoxigenin-labeled uridine triphosphate cRNA probes were synthesized by in vitro transcription using pGEM-T easy plasmids containing T7 or SP6 RNA polymerase promoters according to the manufacturer's protocol (Roche Diagnostics, Meylan, France).
Each PCR fragment was sequenced to determine the orientation of the promoter (T7 or SP6) and the nature of the insert. For each probe, three 12-lmthick cryosections were cut for each of three cyclic and three pregnant animals and then processed for in situ hybridization, as previously described [24] . Each probe was used at a concentration of 500 ng/ml. Negative controls were included by hybridization with sense probes. Images were captured by the Nanozoomer scanner and coupled to digital viewing software (Hamamatsu Photonics KK, Massy, France).
RESULTS

Experiment 1: Immunohistochemical Analysis of Endometrial MU and DC Populations
Our findings indicate that the bovine endometrium plays host to cells of the immune system, including DCs, MOs, and MUs. The LE was primarily devoid of MOs, MUs (CD11b CD11b þ . The total population of CD11b þ cells was quite large in both pregnant and cyclic endometrium and was mainly concentrated in the SS (Fig. 1A) . A transient increase in the number of CD11b þ cells was noted in both pregnant and cyclic endometrium on Day 7 (P , 0.05). There was no clear impact of pregnancy; neither the total number of positive cells nor the cell distribution pattern differed according to pregnancy status (Fig. 1B) .
There was a large population of CD14 þ cells, which were primarily located in the stroma, with highest numbers in the SS in both cyclic and pregnant endometrium ( Fig. 2A) . The distribution pattern did not change with regard to numbers or localization in the cyclic endometrium from Days 5 to 13; however, there was a decrease in total cell number on Day 16, which was reflected in both the SS and DS (Fig. 2B ). In contrast, there was a progressive accumulation of cells from Days 5 to 13 in the endometrium from pregnant animals, and then a decrease on Day 16 (P , 0.05). CD14 þ cell numbers diverged between pregnant and cyclic animals, particularly in the SS (P ¼ 0.02) on Day 13 and in the DS (P ¼ 0.006) on Day 16 (Fig. 2B) . 
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CD172a
þ . CD172a þ cells constituted the largest cell population in terms of total number present in the endometrium. The cells were primarily located in the stromal regions (Fig. 3) . The total cell number was not impacted temporally during the estrous cycle or pregnancy, and did not differ according to pregnancy status (Fig. 4A) . The highest concentration of cells was noted in the SS of cyclic endometrium on Day 5 (P , 0.05); thereafter, the numbers declined to a level that was maintained up to Day 16 (Fig. 4, B and C). The number of CD172a þ cells was significantly higher (2-fold) on Day 7 in the SS of pregnant versus cyclic tissue.
CD11c
The population of CD11c þ cells was small throughout the estrous cycle and early pregnancy, and it was primarily localized in the stromal regions (Fig. 3) . The number of cells localized in the SS of endometrium from pregnant animals increased steadily until Day 13. On Day 16, pregnant animals showed significantly larger accumulations of CD11c þ cells in the DS compared with Days 5 (P , 0.005), 7 (P , 0.001), and 13 (P , 0.06) of pregnancy (Fig. 4, D-F) . The number of CD11c þ cells was significantly higher (10-fold increase) on Day 16 in the DS of endometrium from pregnant compared with cyclic animals (Fig. 4F) .
There was a small population of CD172a þ -CD11c þ cells, which were predominantly localized to the stromal tissue. The total cell number was neither regulated temporally during the estrous cycle or pregnancy, nor impacted by the pregnancy status (Fig. 4G) . However, the number of CD172a þ -CD11c þ cells was significantly higher on 
Experiment 2: Characterization of Endometrial mRNA Expression Profiles of MU/DC-Derived Factors
The mRNA expression profile of a panel of candidate immune factors (n ¼ 11) was characterized in the bovine cyclic and pregnant endometrial tissue. A summary of the covariates significantly affecting candidate gene mRNA expression is presented in Table 1 .
Temporal expression of immune factors during the estrous cycle. The mRNA expression profile of a panel of candidate immune factors (n ¼ 11) was characterized in the bovine endometrium during the early (Day 5/7), mid (Day13), and late (Day 16) luteal phase of the bovine estrous cycle. The mRNA expression levels of three of the genes were regulated temporally during the estrous cycle. Briefly, the expression of IL15 was highest in the mid luteal phase and maintained through the late luteal phase. TGFB2 transcript abundance remained constant throughout the early phase but decreased at the luteal phase, whereas PTX3 was upregulated during the late luteal phase. The fold change differences are shown in Supplemental Table S2 .
Impact of pregnancy on endometrial expression of immune factors: cyclic versus pregnant profiles. Of the 11 genes studied, 5 genes were regulated by pregnancy regardless of stage. There was no effect of pregnancy on the expression MANSOURI-ATTIA ET AL. levels of any of the genes studied on Days 5 and 7. Most pregnancy-regulated genes were first differentially expressed on Day 13 or Day 16, coinciding with initiation of IFNT secretion (Fig. 5) . The mRNA expression of IL12B, ISG15, MCP1, PTX3, and RSAD2 was significantly higher in pregnant tissues on Day 16 compared with their cyclic counterparts. In addition, there was a trend for increased expression of CSF1, IL15, and MCP2. The expression profiles of IL18, TNFA, and TGFB2 did not differ between pregnant and cyclic endometrial tissue samples.
Temporal expression of immune factors during early pregnancy. A total of 8 of the 11 genes studied were regulated temporally during pregnancy. Briefly, TGFB2 exhibited a peak of expression on Day 5 of pregnancy; high expression was maintained on Day 7. There was an upregulation in IL15, ISG15, PTX3, and RSAD2 mRNA expression on Day 13 compared with earlier stages of pregnancy. Coinciding with maternal recognition of pregnancy (MRP), IL15, ISG15, MCP2, PTX3, and RSAD2 were upregulated on Day 16 compared with earlier stages, whereas TGFB2 and IL18 were MATERNAL IMMUNE RESPONSE TO PREGNANCY IN CATTLE downregulated. The fold change differences are reported in Supplemental Table S3 .
Experiment 3: In Vivo Regulation of Pregnancy-Associated Immune Factors by P4
Of the 11 genes studied, 2 were regulated by P4 regardless of stage or status (estrous cycle or pregnancy). The comparison between CN and CH expression profiles showed that the P4 level affected only PTX3 during the estrous cycle; its mRNA expression was upregulated during diestrous. A similar comparison of PN versus PH expression profiles identified two genes that were regulated by P4 during pregnancy; PTX3 was downregulated by P4 on Day 5, whereas IL12B was upregulated by P4 at MRP (Day 16). The results are summarized in Table 2 .
Experiment 4: In Vitro and In Vivo Regulation of PregnancyAssociated Immune Factors by IFNT
The mRNA expression of IL15, MCP2, PTX3, and RSAD2 in endometrial fibroblast cells, as well as IL15, MCP2, and RSAD2 in glandular epithelial cells, was induced within 2 h of culture in the presence of IFNT, whereas ISG15 expression was upregulated in glandular epithelial cells after 24 h of culture (Supplemental Fig. S1 ). The mRNA expression of these factors was also analyzed in nonpregnant endometrial tissue exposed to IFNT in vivo. Briefly, in vivo exposure to IFNT strongly induced ISG15, RSAD2, and MCP2 mRNA expression. The upregulation of MCP1, PTX3, and TNFA expression was more moderate. CSF1, IL12B, IL15, IL18, and TGFB2 were not regulated by IFNT in vivo (Supplemental Fig. S2 ). The fold change differences according to cell type are summarized in Table 3 .
Experiment 5: Immune Factor Expression and Localization During Implantation and Placentation
IL12B, ISG15, and RSAD2 mRNA expression was significantly increased by pregnancy during the implantation period; however, their expression levels were significantly lower on Day 60. In contrast, TGFB2 and TNFA expression appeared to be downregulated by pregnancy during implantation but was induced during the placentation process. MCP2 and PTX3 expression was upregulated by implantation and maintained at this level throughout placentation. Finally, CSF1, IL15, IL18, and MCP1 were not regulated by the implantation period or by the placentation process. The results are illustrated in Figure 6 , and the fold change differences are reported in Supplemental  Table S4 .
In situ hybridization was performed to localize the endometrial expression of two IFNT and one non-IFNTinduced gene; MCP1, MCP2, and TGFB2, respectively. No specific signal was detected in samples hybridized with sense oligonucleotide probes. MCP1 showed faint localization to the LE and GE of cyclic and pregnant cows but was undetectable Figure 7 .
DISCUSSION
Successful embryo implantation requires the perfect synchronization of maternal factors, such as P4, cytokines, lymphokines, growth factors, some polypeptide hormones, and fetal factors, such as IFNT, to promote endometrial receptivity and blastocyst development. The current study presents a detailed characterization of these pregnancy-related changes in the maternal immune system in light of the regulation of myeloid-derived immune cell populations as pregnancy is established in cattle.
MOs/MUs and DCs: Crucial Allies of Pregnancy During MRP and Implantation
Macrophages are one of the major subsets of leukocytes resident in human uterine decidua, for which strong evidence of a role in implantation and placentation exists [29] . The presence of MUs in the pregnant ruminant endometrium has been recorded in late-gestation sheep [30] and in first-, second-, and third-trimester cattle [17] [18] [19] . The findings of the present study demonstrate that in cattle the population of MUs and MOs is expanded in the endometrium as early as Day 13 of pregnancy. This increase was limited to the stromal compartment and suggests a centripetal recruitment of these cells from the SS to the lumen, because the number of CD14 þ cells decreased on Day 16 compared with Day 13 in the SS but remained constant in the DS. At the same time we noted a decrease in CD11b þ cells in the stroma; because CD11b is associated with MO movement through the endothelium [31] , these cells may have migrated to the lumen, or the cells from the DS may have acquired a stationary phenotype by losing their CD11b expression to remain in the endometrial stroma.
Dendritic cells have been shown to accumulate at the maternal-placental interface in both human and murine pregnant uteri prior to implantation and throughout pregnancy, where they have an important role in decidua formation [32] . These cells are implicated in the innate adaptive immune response and are known to induce immune tolerance during pregnancy [33] . Dendritic cells are closely related to MUs, but they are more potent antigen-presenting cells. In mice, DCs appear to be important to the decidualization process, because depletion of uterine DCs results in early pregnancy failure due to impairment of the decidualization process [32] . Similarly, supplementing a mouse model with DCs decreased the rate of spontaneous resorption [34] . The 10-fold increase in CD11c þ cells in pregnant versus cyclic endometrial stroma observed in the current study implies a role for myeloid DC progenitors in the establishment of pregnancy in cattle. Although CD172a þ cells increased in the stroma of pregnant animals on Day 7, CD172a þ -CD11c þ cells increased on Day 16. CD172a and CD11c dual labeling was chosen to confirm DC lineage in the current study, according to earlier observations in the bovine thymus [35] . The number of CD11c þ cells in the pregnant endometrium was much higher than the number of CD172a þ -CD11c þ cells, suggesting an accumulation of immature DCs within the endometrium during early pregnancy. Because the maturation of DCs requires their migration to secondary lymphoid organs [36] , the number of immature DCs is likely to be larger than the number of mature DCs in the endometrium [37] . Furthermore, immature DCs are required for the initiation and maintenance of peripheral tolerance [38] , and their presence in large numbers in the uterine decidua has been associated with the establishment of healthy pregnancies in women [39] .
Conditioned media from trophoblast cells was reported to induce MO-like THP-1 cells to secrete cytokines that are beneficial for trophoblast development [17] . Considering these data in light of the current study, we suggest that trophoblast IFNT modulates subpopulations of MOs/MUs and DCs, probably by either attracting MOs into endometrium or by modulating their differentiation into MUs or DCs, whose cytokine secretions promote embryo development, shape the maternal immune system, and support pregnancy. MANSOURI-ATTIA ET AL.
Although we clearly showed that many of the investigated cytokines (7 of 11) were regulated by pregnancy, regardless of stage or P4 level, ISG15, MCP1, MCP2, PTX3, and RSAD2 are particularly noteworthy because their expression was increased in response to pregnancy and strong evidence in the literature indicates that they are associated with MOs.
Microarray analysis of bovine endometrial tissue has identified ISG15 as one of the most regulated genes during early pregnancy [24, 40] , when it undergoes temporal regulation similar to the expression pattern of IFNT in cattle [41] . Indeed, ISG15 transcription has been shown to be regulated by IFNT in both in vivo and in vitro studies of bovine endometrial tissue [41, 42] , and our studies are in complete agreement with these findings, confirming the importance of ISG15 during ruminant implantation.
As with ISG15, pregnancy status had a significant and highly positive impact on the expression of RSAD2, which was restricted to the events of MRP and implantation. In agreement with findings in sheep [43] , this factor was mediated by both P4 and IFNT in vivo. RSAD2 is a cytoplasmic antiviral protein induced by type I IFN that can inhibit human cytomegalovirus [44] or hepatitis C virus replication [45] , and therefore modulates adaptive immunity. Because RSAD2 mRNA expression is mainly confined to the LE and the stroma [24] , it is likely that its principal role during implantation is the prevention of uterine infection during this critical stage. In agreement with earlier findings [46] , we noted that pregnancy had a positive impact on the expression of MCP1 and MCP2, particularly at the time of MRP, and that expression of both MCPs was readily induced in response to IFNT treatment, as previously shown in sheep [47] . The earlier findings in sheep associated MCP1 and MCP2 expression with eosinophil recruitment to the pregnant endometrium, where they were localized immediately beneath the LE [47] . Using in situ hybridization, we localized MCP mRNA expression to the LE, GE, and SS, but although there is evidence of an increase in the population of endometrial eosinophils during the estrous period in cattle [48] , there are no reports of an increase during MRP or implantation. MCPs are members of the cellular chemoattractant chemokine b subfamily and are recognized as highly potent in the recruitment of MOs in vivo [49] . MCP1 has been shown to regulate MO activation and secretion, and although it 
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is considered to be a proinflammatory factor, it has been suggested to stimulate Th2-type responses in mice [49] . The observed increase in MCP1 and MCP2 expression during pregnancy could be a consequence of the recruitment of MOs/ MUs from the systemic system into the endometrium to enhance a Th2-type response.
In addition to its well-known role in innate immunity, where it is produced in response to proinflammatory signals against selected pathogens [50] , PTX3 has been implicated in angiogenesis [51] , matrix remodeling [52] , and female fertility [53] . Here, we report an increase in PTX3 expression on Day 13 in pregnant versus cyclic endometrium that was maintained through the implantation and placentation process. Dendritic cells are a major source of PTX3, as are fibroblasts, MOs, and MUs [54, 55] . Increased endometrial expression of PTX3 may reflect recruitment and/or activation of MUs/DCs that enhance PTX3 expression. Furthermore, PTX3 expression might be induced by P4 and/or IFNT, because both factors were confirmed as positive regulators in the current study, which is in agreement with in vitro results from human endometrial stromal cells [56] . Because PTX3 deficiency has been reported to compromise implantation in mice [57] , our data imply a potential role for PTX3 during early pregnancy. Dendritic cells constitute a source of IL12, IL15, and IL18, which have been identified as a key trio of human uterine natural killer cell modulators [58] . With regard to the current study, we noted temporal upregulation of IL12B and IL15 mRNA expression during the estrous cycle and early pregnancy, with enhanced expression of IL12B in the pregnant tissue on Day 16. This may be associated with the expansion of the uterine dendritic cells and MU populations during MRP, because IL15 also acts as an MO chemoattractant [59] . Although IL12 and IL15 have been previously classified as Th1-related cytokines, data from women and mice suggest their involvement in endometrial immunoregulation and normal pregnancy [60] [61] [62] . Interestingly, IL18 expression was temporally downregulated in the early pregnant tissue, highlighting a degree of fine tuning in the expression of this cytokine trio that may facilitate both fetal toleration and maternal immunoprotection in cattle.
In contrast to the genes discussed above, the expression of TGFB2 appeared to be downregulated from Day 7 of both the estrous cycle and early pregnancy, and also during implanta- tion. TGFB family members have been previously shown to stimulate extracellular matrix formation and cellular matrixbinding receptors and have been implicated as factors involved in tissue growth and remodeling [63] . Similar to findings previously shown in sheep [64] , TGFB2 expression was mainly localized to the LE, subluminal stroma, and GE (superficial glands), and was strongly downregulated by pregnancy during embryo implantation. In humans, TGFB2 was detected at the fetomaternal interface during the first trimester and was shown in vitro to control trophoblast invasion [65] . Our results lead us to speculate that TGFB2 downregulation during the implantation period is involved in restricting trophoblast invasion of the endometrium. Furthermore, TGFB2 activity could be repressed by its natural inhibitor, decorin [66] , which was shown to be increased during pregnancy in cattle [24] . The suppression of TGFB2 expression appeared to be reversed by Day 60,  suggesting that TGFB2 may play a mitogenic role during placentation, promoting caruncular growth and coordinating epithelial cell development, leading to placentome formation [67] . Moreover, TGFB2 regulation during these critical stages may act to control Mo recruitment or curtail activation to a proinflammatory TNFA secretory cell [68] .
Modest Effect of Elevated P4 on Endometrial Immunomodulation
In cattle, elevated concentrations of circulating P4 in the immediate postconception period are associated with advanced conceptus development, by altering the time or duration of the expression of genes that contribute to the composition of histotroph, whereas low P4 is implicated as a causative factor in low pregnancy rates observed in dairy cows [20, 21, 69] . The data in the current study indicate that elevating P4 has a modest impact on the uterine immunological profile during the estrous cycle and early pregnancy, and confirm the importance of appropriate signaling by the embryo as the key driver of the maternal immune response to pregnancy.
In conclusion, the present study details novel immunomodulatory events of early pregnancy in cattle and proposes a role for MOs/MUs and DCs in the maternal immunotolerization toward the embryo by strengthening the cytokine regulation profiles. This study highlights some immune factors, including MCP1, MCP2, PTX3, RSAD2, and TGFB2, that may play an integral role during early pregnancy, and particularly around the time of MRP and implantation.
